# OnCo record goserelin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/goserelin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "goserelin" ;
  schema:name "Goserelin / leuprolide (ovarian function suppression)"@en ;
  schema:description "Monthly or 3-monthly injections that switch off the ovaries, letting premenopausal women use aromatase inhibitors and lowering recurrence in higher-risk cases."@en ;
  schema:url <https://onco.cc/drugs/goserelin/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Goserelin> ;
  owl:sameAs <http://www.wikidata.org/entity/Q1992653> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=Goserelin> ;
  onco:status "approved" ;
  onco:modality "GnRH agonist" ;
  schema:alternateName "Zoladex; Lupron" ;
  onco:approval "US 1989: Advanced breast cancer (goserelin); prostate cancer" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-early-high-risk/> ;
  onco:technologies <https://onco.cc/technologies/endocrine-therapy/> ;
  onco:targets <https://onco.cc/targets/estrogen-receptor/> ;
  onco:companies <https://onco.cc/companies/eurofarma/> ;
  onco:terms <https://onco.cc/terms/ovarian-function-suppression/> ;
  onco:trials <https://onco.cc/trials/soft-text/>, <https://onco.cc/trials/nct02960022/> .